Good Clinical Practice eRegs & Guides - For Your Reference Book 6

Nonfiction, Health & Well Being, Medical, Reference, Drug Guides, Research
Cover of the book Good Clinical Practice eRegs & Guides - For Your Reference Book 6 by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C., Biopharma Advantage Consulting L.L.C.
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C. ISBN: 1230000220524
Publisher: Biopharma Advantage Consulting L.L.C. Publication: February 22, 2014
Imprint: Language: English
Author: FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
ISBN: 1230000220524
Publisher: Biopharma Advantage Consulting L.L.C.
Publication: February 22, 2014
Imprint:
Language: English
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

ICH - Safety Guidelines S1A – S9 

S1A Guideline on the Need for Carcinogenicity Studies 

S1B Testing for Carcinogenicity of Pharmaceuticals 

S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals 

S2(R1) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use 

S3A Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies 
Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies 

S4 Duration of Chronic Toxicity Testing in Animals (Rodent and Non Rodent Toxicity Testing) 

S5(R2) Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility 

S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals 

S7A Safety Pharmacology Studies For Human Pharmaceuticals 

S7B The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) By Human Pharmaceuticals 

S8 Immunotoxicity Studies for Human Pharmaceuticals 

S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

ICH - Safety Guidelines S1A – S9 

S1A Guideline on the Need for Carcinogenicity Studies 

S1B Testing for Carcinogenicity of Pharmaceuticals 

S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals 

S2(R1) Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use 

S3A Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies 
Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies 

S4 Duration of Chronic Toxicity Testing in Animals (Rodent and Non Rodent Toxicity Testing) 

S5(R2) Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility 

S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals 

S7A Safety Pharmacology Studies For Human Pharmaceuticals 

S7B The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) By Human Pharmaceuticals 

S8 Immunotoxicity Studies for Human Pharmaceuticals 

S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
 

More books from Research

Cover of the book Handling Qualitative Data by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book The SAGE Handbook of Strategic Supply Management by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Researching the Vulnerable by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Cases on Consumer-Centric Marketing Management by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book FMEA Using Uncertainty Theories and MCDM Methods by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Advances in Business, Operations, and Product Analytics by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Inflection Points-Risk Readiness & Failure Fearless! by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Analyzing Rational Crime — Models and Methods by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book A Concise Introduction to Mixed Methods Research by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Customer Processes and their application to Mobile Devices by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Doing Health Anthropology by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Face-To-Face with Doug Schoon Volume I by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Sustainable Supply Chains by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Writing Qualitative Inquiry by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
Cover of the book Multicriteria Analysis by FDA, Biopharma Advantage Consulting L.L.C., eRegs And Guides a Biopharma Advantage Consulting L.L.C.
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy